Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2010
10/07/2010WO2010114162A1 Novel salt of 1,3,5-triazine-2,4,6-triamine derivative
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010112116A1 Heterocyclic compounds as autotaxin inhibitors
10/07/2010WO2010065824A3 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10/07/2010WO2009109388A8 Crystal forms of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide and methods for their preparation
10/07/2010WO2009090237A3 Fungicide hydroximoyl-tetrazole derivatives
10/07/2010US20100256392 Polymorphs of sunitinib base and processes for preparation thereof
10/07/2010US20100256388 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation
10/07/2010US20100256387 Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/07/2010US20100256375 Substituted benzimidazoles and methods of preparation
10/07/2010US20100256371 Processes for the preparation of bosentan and its intermediates thereof
10/07/2010US20100256357 Heterocycles useful as inhibitors of carbonic anhydrase
10/07/2010US20100256208 Novel process
10/07/2010US20100256192 3.1.0 bicyclic glyt1 inhibitors and methods of making and using same
10/07/2010US20100256170 Pyrazole compounds useful as protein kinase inhibitors
10/07/2010US20100256166 Novel Hydantoin Derivatives as Metalloproteinase Inhibitors
10/07/2010US20100256165 Large conductance calcium-activated k channel opener
10/07/2010US20100256154 Isoxazolo-pyrazine derivatives
10/07/2010US20100256151 Novel salt of 1,3,5-triazine-2,4,6-triamine derivative
10/07/2010US20100256149 Novel arylamino n-heteraryl compounds as mek inhibitors
10/07/2010US20100256144 Kallikrein 7 modulators
10/07/2010US20100256141 Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
10/07/2010US20100256137 Indazolamide derivatives
10/07/2010US20100256121 Substituted diazepan orexin receptor antagonists
10/07/2010US20100256120 Amide derivatives
10/07/2010US20100256119 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010US20100256109 Azetidines As EP2 Antagonists
10/07/2010US20100256108 Indazole acrylic acid amide compound
10/07/2010US20100254910 Methods and compositions for diagnostic and therapeutic targeting of cox-2
10/07/2010US20100253208 Bis-phenanthroimidazolyl compound and electroluminescent device using the same
10/07/2010US20100252433 Novel optical labeling molecules for proteomics and other biological analyses
10/07/2010CA2757413A1 Heterocyclic compounds as autotaxin inhibitors
10/07/2010CA2757188A1 Pyrimidine compound
10/07/2010CA2757019A1 Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide
10/06/2010EP2236500A1 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof
10/06/2010EP2236499A1 Heterocyclic compound, and light-emitting element, light-emitting device, lighting device, and electronic appliance using heterocyclic compound
10/06/2010EP2235004A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolmone derivatives as kinase inhibitors useful in the treatment of cancer
10/06/2010EP2234989A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists
10/06/2010EP2234986A2 Sulfamides as zap-70 inhibitors
10/06/2010EP2234984A1 Fluoroalkyl substituted benzimidazole cannabinoid agonists
10/06/2010EP2234981A1 Novel imidazole-substituted arylamides
10/06/2010EP2234978A1 Carbamoyl compounds as dgat1 inhibitors 190
10/06/2010EP2234964A1 Intermediate compounds for the preparation of meso-substituted cyanine, merocyanine and oxonole dyes
10/06/2010EP2234615A1 4-imidazolidinones as kv1.5 potassium channel inhibitors
10/06/2010EP1874760B1 (lh-ind0l-7-yl)-( (pyrimidin-2 -yl-amino) methanone derivatives and related compounds as igf-rl inhibitors for treating cancer
10/06/2010EP1421105B1 Anti-cancer cyclopenta¬g quinazoline compounds
10/06/2010EP1309569B1 N-aryl-{4-[7-(alkoxy)quinazolin-4-yl]piperazinyl}carboxamide derivatives as PDGFRs inhibitors
10/06/2010EP1268446B1 Method for producing asymmetrical 4,6-bis(aryloxy)pyrimidine derivatives
10/06/2010CN1606444B Inhibitors of human phosphatidyl-inositol 3-kinase delta
10/06/2010CN101855221A Pyridazinone derivatives as PARP inhibitors
10/06/2010CN101851235A Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same
10/06/2010CN101851230A Heterocyclic compound, and light-emitting element, light-emitting device, lighting device, and electronic appliance using heterocyclic compound
10/06/2010CN101851211A Novel piperazinoamide compound
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/05/2010US7807844 Reaction product of N-methylpyrrole, N-methylimidazole, 4-aminobutyric acid and B-alanine that can be folded into a U-shaped conformation at the gamma -aminobutyrate unit in a minor groove of a double helix region; conjugates with fluorescein isothiocyanate; antiproliferative agents; restenosis
10/05/2010US7807837 Scalable synthesis of imidazole derivatives
10/05/2010US7807709 3,4-substituted pyrrolidines; renin inhibitors; cardiovascular disorders, kidney disorders, neurodegenerative diorders and other diseases related to renin; e.g. N-((3S*,4S*)-4-{[Cyclopropyl-(4-methyl-pentanoyl)-amino]-methyl}-pyrrolidin-3-ylmethyl)-N-isopropyl-4-methoxy-3-(3-methoxy-propoxy)-benzamide
10/05/2010US7807703 Herbicides; pesticides
10/05/2010US7807697 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile
10/05/2010US7807694 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections
10/05/2010US7807690 such as 2-(3-aminopyridin-2-yl)-5-[(1-imino-2,3-dihydro-1H-isoindol-5-ylamino)-(8-methoxy-4H-benzo[1,3]dioxin-6-yl)methyl]-2,4-dihydro-1,2,4-triazol-3-one, having serine protease inhibiting activity, and particularly excellent inhibiting activity against blood-coagulation factor VIIa
10/05/2010US7807689 such as 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile, used for the treatment of breast cancer and non-insulin depepndent diabetes
10/05/2010US7807678 Peptidomimetics of biologically active metallopeptides
10/05/2010US7807672 Compounds that are ERK inhibitors
10/05/2010US7807671 viricides such as 1-(7-bromo-4-fluoro-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-(4-(1-phenyl-1H-tetrazol-5-yl)piperazin-1-yl)ethane-1,2-dione , used for the treatment of HIV and AIDS
09/2010
09/30/2010WO2010111573A1 Compounds as cannabinoid receptor ligands
09/30/2010WO2010111437A1 Antiviral compounds and uses thereof
09/30/2010WO2010111381A2 Useful pharmaceutical salts of 7-[(3r, 4r)-3-hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmethyl]-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-one
09/30/2010WO2010110400A1 Heterocyclic compound
09/30/2010WO2010108921A1 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors
09/30/2010WO2010079431A3 Compounds for the prevention and treatment of cardiovascular disease
09/30/2010WO2010074409A3 3-aminopyrrolidine derivatives as ccr2 antagonists
09/30/2010US20100249413 Stabilized pharmaceutical composition
09/30/2010US20100249405 Organic Compounds
09/30/2010US20100249401 Process for the preparation of sterically hindered nitroxyl ethers
09/30/2010US20100249400 Novel dihydronaphthalene compound and use thereof
09/30/2010US20100249385 Water-soluble fluoro-substituted cyanine dyes as reactive fluorescence labelling reagents
09/30/2010US20100249276 Curatives for epoxy compositions
09/30/2010US20100249201 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation
09/30/2010US20100249197 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
09/30/2010US20100249192 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
09/30/2010US20100249190 Hepatitis C Virus Inhibitors
09/30/2010US20100249181 HIV Protease Inhibiting Compounds
09/30/2010US20100249162 Process for the introduction of hydroxyethoxy side chain in bosentan
09/30/2010US20100249159 Rho-kinase inhibitors
09/30/2010US20100249157 Lpa receptor antagonist
09/30/2010US20100249148 Novel pyrimidine compounds having benzyl (heterocyclic methyl) amine structure and medicament comprising the same
09/30/2010US20100249146 Heteroaryloxy quinazoline derivative
09/30/2010US20100249127 Substituted indolo-pyridinone compounds
09/30/2010US20100249117 Factor xa inhibitors
09/30/2010US20100249096 Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
09/30/2010US20100249093 Substituted Heteroarylpiperidine Derivatives As Melanocortin-4 Receptor Modulators
09/30/2010US20100249092 Heteroaryl compounds and uses thereof
09/30/2010US20100249091 Amide Compounds Useful in Therapy
09/30/2010US20100249087 Compounds as cannabinoid receptor ligands
09/30/2010US20100249086 Compounds As Cannabinoid Receptor Ligands
09/30/2010US20100249085 Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
09/30/2010US20100249068 Substituted nucleoside and nucleotide analogs
09/30/2010US20100249049 Arylalkylamine compound and process for preparing the same
1 ... 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 ... 626